Loading in 2 Seconds...
Loading in 2 Seconds...
CU-IBC Institutional Biosafety Committee formerly the Recombinant DNA Committee . Frank Cantone, Interim IBC Chair Cornell University Biological Safety Officer Maria Golonski, Executive Secretary. What does the IBC do?.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Frank Cantone, Interim IBC Chair
Cornell University Biological Safety Officer
Maria Golonski, Executive Secretary
Review all University research and teaching activities involving the use of REGULATED biological agents, toxins, and recombinant DNA molecules.
Ensure that personnel and facilities are in compliance with all external regulations and applicable University policies.
Recommend policies to guide principal investigators and EH&S in carrying out the University's Biosafety Program, i.e., acquisition, use, training, transfer, storage, disposal, and emergency response procedures for all biohazardous materials emphasizing the protection of personnel, the general public, and the environment.
Safety - Containment - Training
Standing Committee of the Faculty Senate
Vice Provost for Research –> SPS & EH&S
Is now affiliated with ORIA (Office of Research Integrity & Assurance) – Compliance Office
CU Faculty and Staff with various expertise from different fields
At least two members shall not be affiliated with the university
Who is the IBC?
Maria Golonski – Executive Secretary
Jean Bonasera – Plant Pathology
Frank Cantone (Interim Chair)– EH&S
Alice Churchill – Plant Pathology
Walter DeJong – Plant Genetics
Ed Dubovi – Vet. Diagnostic Lab.
Hazel Fromm – Community Member
Susheng Gan – Horticulture
Paul Jennette – Biosafety Engineer
Pat McDonough – Pop Med & Diag
Christy Michaels – Community Member
Keith Perry – Plant Pathology
Mark Roberson – Biomedical Science
Jean Siracusa – Community Member
Chris Smart – Plant Pathology Geneva
Martin Wiedmann – Food Science
Charlie Fay – VP Res. Admin.
Charles Walcott – Assoc. Dean Faculty
Steve Hughes - Gannett Clinic
Bob Richardson - Vice Provost Res.
CU regulates all rDNA projects, incl. NIH-exempt projects
Infectious Pathogens – CDC, USDA, NIH, ABSAHuman, Animal, Plant
Biological Toxins -CDC
All research projects involving regulated biohazardous materials must be registered with the CU-IBC via a MUA (Memorandum of Understanding and Agreement)
If rDNA, GMO or Biological Agent, boxes are checked - it triggers an SPS (IBC) response.
PI receives an email indicating that an MUA is required prior to the release of funds. Some agencies require approval when grant is submitted.
Determine need for a MUA
New or Revised
PI will be informed of status of MUA and will be directed to submit a new protocol or an ammendment
Information, Instructions, and Forms are on the website
This should be consulted prior to submitting a Form 10 and any MUA forms.
Proper forms must be completed in full
Electronic submission is here!!
Questions regarding the forms can be directed to Maria Golonski (mg352) at 255-7219 or Frank Cantone (fac2) at 254-4888
Committee Chair and Biological Safety Officer review all MUAs
Exempt projects are approved by the chair
Non-exempt projects are assigned to a 3 person subcommittee for review
Subcommittee reports on review and recommends project for approval
Provisional approval may be granted at that time
Funding cannot be released prior to this
The IBC meets the third Thursday of even months
All meetings are open to the public – announced in the Ithaca Journal and Cornell Daily Sun
At the meetings, all non-exempt proposals with completed subcommittee reviews are discussed and voted upon
All MUAs are good for 3 years from the date it was approved, HOWEVER…..
Each year an annual questionnaireis required.
A full review by the IBC is required every third year on all proposals
All Research involving rDNA and biohazardous materials,
sponsored or not,
is subject to all the compliance issues just discussed.
Compliance is the responsibility of the PI, but the Dept. Chair/Head has an obligation to ensure all PIs are aware of the rules.